The present invention provides methods for inducing an antigen-specific immune response by administering allogeneic antigen-presenting cells to a subject. In another aspect, an effective amount of autologous antigen-presenting cells are co-administered to a subject.
CROSS-REFERENCE TO RELATED APPLICATION
This application is a continuation of international application number PCT US99/06037, filed 19 Mar. 1999.
This application claims priority under 35 U.S.C. .sctn.119(e) to U.S. Provisional Application No. 60/078,900, filed Mar. 20, 1998, the contents of which are hereby incorporated by reference into the present disclosure.
